These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16927679)

  • 1. Artepillin C isoprenomics: design and synthesis of artepillin C analogues as antiatherogenic antioxidants.
    Uto Y; Ae S; Hotta A; Terao J; Nagasawa H; Hori H
    Adv Exp Med Biol; 2006; 578():113-8. PubMed ID: 16927679
    [No Abstract]   [Full Text] [Related]  

  • 2. Artepillin C isoprenomics: design and synthesis of artepillin C isoprene analogues as lipid peroxidation inhibitor having low mitochondrial toxicity.
    Uto Y; Ae S; Koyama D; Sakakibara M; Otomo N; Otsuki M; Nagasawa H; Kirk KL; Hori H
    Bioorg Med Chem; 2006 Aug; 14(16):5721-8. PubMed ID: 16697207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turmeric and laurel aqueous extracts exhibit in vitro anti-atherosclerotic activity and in vivo hypolipidemic effects in a zebrafish model.
    Jin S; Hong JH; Jung SH; Cho KH
    J Med Food; 2011 Mar; 14(3):247-56. PubMed ID: 21332404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LDL cholesterol: the lower the better.
    Martin SS; Blumenthal RS; Miller M
    Med Clin North Am; 2012 Jan; 96(1):13-26. PubMed ID: 22391248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs targeting atherosclerosis: current and emerging approaches.
    Manolopoulos VG; Tavridou A
    Curr Pharm Des; 2009; 15(27):3091-3. PubMed ID: 19754383
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-atherogenic effects of 3,4-Dihydroxy hydrocinnamides.
    Lee S; Lee CH; Oh JH; Kim EE; Choi YK; Kim EH; Lee WS; Bok SH; Jeong TS
    Bioorg Med Chem Lett; 2003 Aug; 13(16):2681-2. PubMed ID: 12873493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing potential agents against atherosclerosis: Design, synthesis and pharmacological evaluation of novel dual inhibitors of oxidative stress and Squalene Synthase activity.
    Katselou MG; Matralis AN; Kourounakis AP
    Eur J Med Chem; 2017 Sep; 138():748-760. PubMed ID: 28728107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and action of antiatherogenic antioxidants.
    Cynshi O; Tamura K; Niki E
    Methods Mol Biol; 2010; 610():91-107. PubMed ID: 20013174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel keto-enamine Schiffs bases from 7-hydroxy-4-methyl-2-oxo-2H-benzo[h] chromene-8,10-dicarbaldehyde as potential antidyslipidemic and antioxidant agents.
    Sashidhara KV; Rosaiah JN; Bhatia G; Saxena JK
    Eur J Med Chem; 2008 Nov; 43(11):2592-6. PubMed ID: 18063225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.
    Sashidhara KV; Dodda RP; Sonkar R; Palnati GR; Bhatia G
    Eur J Med Chem; 2014 Jun; 81():499-509. PubMed ID: 24871900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of lipidomics.
    Stock J
    Atherosclerosis; 2012 Mar; 221(1):38-40. PubMed ID: 22178427
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of 5-aryl-6-cinnamoyl-7-methyl-flavanones as novel antioxidants and antihyperlipidemics.
    Sharma A; Anand N; Sharma R; Chaturvedi U; Khanna AK; Bhatia G; Tripathi RP
    J Enzyme Inhib Med Chem; 2012 Apr; 27(2):211-22. PubMed ID: 21657950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New multifunctional Di-tert-butylphenoloctahydro(pyrido/benz)oxazine derivatives with antioxidant, antihyperlipidemic, and antidiabetic action.
    Ladopoulou E; Matralis AN; Kourounakis AP
    J Med Chem; 2013 Apr; 56(8):3330-8. PubMed ID: 23581491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of new N-acryl-1-amino-2-phenylethanol and N-acyl-1-amino-3-aryloxypropanols and evaluation of their antihyperlipidemic, LDL-oxidation and antioxidant activity.
    Sarkar S; Sonkar R; Bhatia G; Tadigoppula N
    Eur J Med Chem; 2014 Jun; 80():135-44. PubMed ID: 24769351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A paradigm shift in the treatment of atherosclerosis.
    Ferrières J
    Arch Cardiovasc Dis; 2015; 108(6-7):337-9. PubMed ID: 26148633
    [No Abstract]   [Full Text] [Related]  

  • 16. Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox.
    González-Gay MA; González-Juanatey C
    Ann Rheum Dis; 2014 Jul; 73(7):1281-3. PubMed ID: 24907362
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of fufang zhenzhu tiaozhi capsule on lipid metabolism in atherosclerotic rabbits].
    Tang CP; Jiang T; Guo J; Wei YP; Yang CY; Chen FC
    Zhong Yao Cai; 2010 Aug; 33(8):1285-9. PubMed ID: 21213542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel benzoxazine and benzothiazine derivatives as multifunctional antihyperlipidemic agents.
    Matralis AN; Katselou MG; Nikitakis A; Kourounakis AP
    J Med Chem; 2011 Aug; 54(15):5583-91. PubMed ID: 21702499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglycerides: how much credit do they deserve?
    Kohli P; Cannon CP
    Med Clin North Am; 2012 Jan; 96(1):39-55. PubMed ID: 22391250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of resveratrol on atherosclerosis.
    Fan E; Zhang L; Jiang S; Bai Y
    J Med Food; 2008 Dec; 11(4):610-4. PubMed ID: 19053850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.